In silico prediction of substrate properties for ABC-multidrug transporters.

Expert Opinion on Drug Metabolism & Toxicology
Michael A DemelG F Ecker

Abstract

Overexpression of ABC (ATP-binding cassette)-type drug efflux pumps, such as ABCB1, ABCC1 and ABCG2 in cancer cells confers multi-drug resistance (MDR) and represents a major cause of treatment failures in cancer therapy. Furthermore, there is increasing evidence for the important contribution of ABC-transporters to bioavailability, distribution, elimination and blood-brain barrier permeation of drug candidates. This review presents an overview on the different computational methods and models pursued to predict ABC-transporter substrate properties of drug-like compounds. They range from linear discriminant analysis to pharmacophore modelling and machine learning algorithms. Many of these models show a satisfying performance within the study-specific, defined chemical space but general applicability for the whole drug-like chemical space still needs to be proven. First attempts aiming towards selectivity profiling for ligands of the two polyspecific transporters ABCB1 and ABCG2 is also discussed. This might pave the way for a pharmacological profiling of compound series with special focus on their ADMET (absorption, distribution, metabolism, excretion and toxicity) properties.

References

Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·F ThiebautM C Willingham
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·H L PearceW T Beck
Nov 15, 1993·Biochemical and Biophysical Research Communications·M GarrigosS Orlowski
Jul 15, 1994·Biochemical and Biophysical Research Communications·A R SafaR L Fine
Mar 10, 1998·European Journal of Biochemistry·A Seelig
Dec 21, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·A Seelig, E Landwojtowicz
Apr 27, 2001·Toxicology Letters·O van Tellingen
Mar 21, 2002·Nature Reviews. Cancer·Michael M GottesmanSusan E Bates
Apr 19, 2002·Journal of Medicinal Chemistry·Julie E PenzottiPeter D J Grootenhuis
Apr 19, 2002·Molecular Pharmacology·Sean EkinsSteven A Wrighton
Nov 19, 2002·Molecular Pharmacology·Alexia GarriguesStéphane Orlowski
Jan 22, 2003·Advanced Drug Delivery Reviews·Alfred H Schinkel, Johan W Jonker
Jun 27, 2003·Journal of Computer-aided Molecular Design·Christian KleinGerhard F Ecker
Jan 27, 2004·Journal of Chemical Information and Computer Sciences·Marc Adenot, Roger Lahana
Mar 5, 2004·Journal of Pharmaceutical Sciences·Vijay K GombarCosette S Serabjit-Singh
Jun 19, 2004·Journal of Drug Targeting·Remigijus DidziapetrisAlanas Petrauskas
Jul 27, 2004·Journal of Chemical Information and Computer Sciences·Y XueY Z Chen
Aug 25, 2004·Cancer Cell·Gergely SzakácsMichael M Gottesman
Apr 15, 2005·Journal of Medicinal Chemistry·Giovanni CianchettaRoy J Vaz
Jun 1, 2005·Journal of Chemical Information and Modeling·Yong-Hua WangLing Yang
Jan 25, 2006·Journal of Pharmaceutical Sciences·Miguel Angel CabreraMarival Bermejo
Mar 7, 2006·Nature Reviews. Drug Discovery·Gergely SzakácsMichael M Gottesman
May 23, 2006·Journal of Chemical Information and Modeling·Patricia de Cerqueira LimaAlexander Tropsha
Jul 15, 2006·Nature Biotechnology·Gaia V PaoliniAndrew L Hopkins
Jul 25, 2006·Journal of Chemical Information and Modeling·Elisabet Gregori-Puigjané, Jordi Mestres
Sep 1, 2006·Nature·Roger J P Dawson, Kaspar P Locher
Sep 26, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Cheng ChangSean Ekins
Sep 29, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Christiane Pauli-Magnus, Peter J Meier
Nov 14, 2006·Advanced Drug Delivery Reviews·Cheng ChangPeter W Swaan
Nov 28, 2006·Journal of Chemical Information and Modeling·Jordi MestresScott Boyer
Dec 23, 2006·Science·Geoffrey ChangAndy P Chen
Feb 9, 2007·Nature Biotechnology·Michael J KeiserBrian K Shoichet

❮ Previous
Next ❯

Citations

Feb 24, 2011·Journal of Medicinal Chemistry·Fabio BroccatelliGabriele Cruciani
Sep 10, 2013·BMC Pharmacology & Toxicology·Ahmed E EnayetallahMathew T Pletcher
Aug 3, 2011·Future Medicinal Chemistry·Rita Schwaha, Gerhard F Ecker
Nov 29, 2011·Drug Discovery Today·Lei ChenTingjun Hou
May 5, 2011·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Mario A QuevedoMargarita C Briñón
Aug 6, 2010·Brain Research Reviews·Filipa Lourenço CardosoMaria Alexandra Brito
Nov 26, 2009·Chemistry & Biodiversity·Michael A DemelGerhard F Ecker
Oct 26, 2012·Chemical Biology & Drug Design·Sheng-lie ZhangQi-dong You
Apr 12, 2010·Molecular Informatics·Freya Klepsch, Gerhard F Ecker
Sep 23, 2014·Chemistry & Biology·Bradley Croy DoakJan Kihlberg
May 12, 2015·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Syed SubhaniKaiser Jamil
Apr 18, 2012·Journal of Medicinal Chemistry·Stephen A Hitchcock
Dec 23, 2016·Medicinal Research Reviews·Diana Peña-SolórzanoCristian Ochoa-Puentes
Dec 1, 2017·Current Medicinal Chemistry·Santiago VilarEugenio Uriarte
Jan 1, 2012·Current Protocols in Chemical Biology·Sivaraman DandapaniCraig J Thomas
Jun 7, 2017·Physical Biology·Panagiotis E TheodorakisOmar K Matar
Apr 15, 2017·International Journal of Medicinal Chemistry·Steven V MolinskiSaumel Ahmadi
Mar 17, 2021·Journal of Medicinal Chemistry·Vigneshwaran NamasivayamSven Marcel Stefan
Jul 3, 2020·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Jelena DinićIvanka Tsakovska

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood-Brain Barrier Transport in Neurodegeneration

The blood brain barrier is important for regulating the movement of biomolecules in and out of the brain. For example, membrane transporters in the blood brain barrier can be essential for regulating drug movement and dysregulation of these processes may play a role in neurodegeneration. This feed follows the latest research on this topic.